Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • ZM vs GSK✓SelectedUSD · GSKZM vs GSK performance historyLatest closeAs of+2.15%11/13
Stock and ETF performance explorer

ZM vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-62.2%
GSK return
+44.4%
Excess return
-106.6%
Maximum drawdown
-79.1%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D+2.1%+0.5%+1.6%+2.1%
7D+11.0%+1.1%+9.9%+10.9%
30D+5.6%+6.3%-0.7%+5.0%
3M-9.1%+1.8%-11.0%-9.3%
6M-2.6%+1.7%-4.2%-2.9%
YTD+15.7%+6.5%+9.1%+13.9%
1Y+18.8%+9.5%+9.3%+16.4%
3Y+62.2%+65.3%-3.1%+46.2%
All-62.2%+44.4%-106.6%-65.3%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling